Compounds > 1,3,6-trihydroxy-8-n-propylanthraquinone
Page last updated: 2024-12-08
1,3,6-trihydroxy-8-n-propylanthraquinone
Description
1,3,6-trihydroxy-8-n-propylanthraquinone is a chemical compound with the molecular formula C17H14O6. It is a type of anthraquinone, a class of organic compounds known for their vibrant colors and potential biological activity.
**Structure and Properties:**
* It's a bright yellow solid with a melting point of 262-265 °C.
* It contains three hydroxyl groups (-OH) and a propyl group (-CH2CH2CH3) attached to the anthraquinone core.
**Importance in Research:**
1,3,6-trihydroxy-8-n-propylanthraquinone has garnered interest in research due to its potential applications in various fields, including:
* **Antioxidant Activity:** Anthraquinones are known for their potent antioxidant properties, which could be valuable in preventing oxidative damage to cells and tissues. This compound has shown promising antioxidant activity in laboratory studies.
* **Anti-Inflammatory Properties:** Studies suggest it might possess anti-inflammatory effects. This potential makes it a candidate for research into treating inflammatory conditions like arthritis and inflammatory bowel disease.
* **Antibacterial and Antifungal Activity:** Some anthraquinones exhibit antibacterial and antifungal properties, making them potential candidates for developing new antimicrobial agents.
* **Cancer Research:** This compound's potential to inhibit the growth of cancer cells is under investigation. Its mechanism of action in cancer cells is being explored.
* **Dye and Pigment Applications:** Anthraquinones are used extensively in the dye and pigment industry for their vibrant colors. The specific properties of 1,3,6-trihydroxy-8-n-propylanthraquinone could make it suitable for specific applications.
**Note:**
While promising, research on 1,3,6-trihydroxy-8-n-propylanthraquinone is ongoing. Further studies are needed to fully understand its safety, efficacy, and potential clinical applications. It's important to consult with a healthcare professional before using any substances, including potential medicinal compounds, for therapeutic purposes.
1,3,6-trihydroxy-8-n-propylanthraquinone: from Streptomyces sp. No. 1128; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 195786 |
CHEBI ID | 82001 |
SCHEMBL ID | 3277225 |
MeSH ID | M0220458 |
Synonyms (13)
Synonym |
r1128a |
135161-96-5 |
1,3,6-trihydroxy-8-propylanthracene-9,10-dione |
C18840 |
r 1128a |
9,10-anthracenedione, 1,3,6-trihydroxy-8-propyl- |
1,3,6-trihydroxy-8-n-propylanthraquinone |
r-1128a |
CHEBI:82001 |
SCHEMBL3277225 |
DTXSID40159268 |
Q27155681 |
r1128 a |
Drug Classes (1)
Class | Description |
trihydroxyanthraquinone | A member of the class of hydroxyanthraquinones carrying three hydroxy substituents. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.40
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.40 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.20 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (20.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |